Back Rod57Oncolytic virus • en.wikipedia.org

Top edits to an page All edits made to a page by one user, in chronological order.

Page Oncolytic virus (Log · Page History)
User Rod57 (Edit Counter· Top Edits)
Total edits 47
Minor edits 18 (38.3%)
(Semi-)automated edits 0 (0%)
Reverted edits 0 (0%)
atbe1 51.4
Added (bytes)2 7,534
Deleted (bytes) -3,006
Minor edits · 18 (38.3%)
Major edits · 29 (61.7%)
(Semi-)automated edits · 0 (0%)
Manual edits · 47 (100%)
Reverted edits · 0 (0%)
Unreverted edits · 47 (100%)
1 Average time between edits (days)
2 Added text is any positive addition that wasn't reverted (approximate)
Date Links Size Edit summary
Diff · History 372 Clinical research: Note ONCOS-102 in ph 2
Diff · History 11 Approved therapeutic agents: virus]]
Diff · History 110 Tumour targeting: {{further information|Oncolytic adenovirus}} & move {{further information
Diff · History 476 Started phase I: *ONCOS-102 is an engineered human serotype 5/3 adenovirus coding for human GM-CSF ... <ref
Diff · History 4 Started phase I: [[
Diff · History 500 ===Other=== The maraba virus, first identified in Brazilian sandflies, is being tested clinically.<ref & fix/swap section/subsection
Diff · History 269 Started phase I: *DNX-2401 is an oncolytic adenovirus with US Orphan drug status for glioma.<ref
Diff · History -536 Approved therapeutic agents: trim out of date text
Diff · History 116 Clinical research: ===Started phase III=== etc - most need updates
Diff · History 46 Oncolytic immunotherapy: Others in clinical trials include JX-594.
Diff · History 248 Possible applications: ===Oncolytic immunotherapy===
Diff · History 2 ==Oncolytic viruses in conjunction with existing cancer therapies== Move further down article to fit
Diff · History 403 Clinical research: split out : ==Approved therapeutic agents== now T-VEC approved
Diff · History 51 Oncolytic viruses in conjunction with existing cancer therapies: ===Pre-clinical research===
Diff · History 4 Directed evolution: [[
Diff · History 32 top: (OncoVex, T-VEC) recently (Jan 2012) , [[
Diff · History 13 Clinical research: Move less developed ones further down section, [[
Diff · History -79 Clinical research: remove personnel detail and combine the 2 JX-594 lines
Diff · History 4 Possible applications: [[
Diff · History 646 Clinical research: cavatek ref for phase II
Diff · History 148 Clinical research: [[, <ref
Diff · History 329 Clinical research: REOLYSIN news etc
Diff · History 46 Clinical research: H101=oncorine
Diff · History 278 Clinical research: resolyn ref and oncorine
Diff · History 45 Clinical research: TNF gene therapy
Diff · History 186 Possible applications: ct ref
Diff · History 3 Immune response: // {{fact
Diff · History -235 Possible applications: rm purple/advocay prose
Diff · History 116 Possible applications: ref & [[
Diff · History 17 Possible applications: {{fact|Jan 2009}}
Diff · History 11 Clinical research: [[GM-CSF|
Diff · History 22 Clinical research: (Ad5/3-D24-GMCSF)
Diff · History 414 Clinical research: *TNFerade failed a phase III trial for pancreatic cancer.<ref>
Diff · History 8 Possible applications: {{fact
Diff · History 23 History: H101
Diff · History 8 Possible applications: [[
Diff · History 1,136 Clinical research: paste in ====Oncolytic viruses in conjunction with existing cancer therapies==== + text from below
Diff · History -1,132 Oncolytic viruses in conjunction with existing cancer therapies: cut section to move up
Diff · History 43 Oncolytic viruses in conjunction with existing cancer therapies: ==See also== virotherapy
Diff · History 881 Possible applications: paste text from lower section as new ===Clinical research===
Diff · History -889 Oncolytic viruses in conjunction with existing cancer therapies: cut to move up
Diff · History 19 Oncolytic viruses in conjunction with existing cancer therapies: GM-CSF]] (see above)
Diff · History -135 Possible applications: rm ad, {{fact
Diff · History 179 Oncolytic viruses in conjunction with existing cancer therapies: CGTG-102 ref
Diff · History 257 Oncolytic viruses in conjunction with existing cancer therapies: JX-584 should have been JX-594 - add refs & detail
Diff · History 19 Oncolytic viruses in conjunction with existing cancer therapies: Onyx-015 Abandoned in 2000.
Diff · History 39 Oncolytic viruses in conjunction with existing cancer therapies: {{fact, [[
All times are in UTC.
No tags for this post.